organogenesis.com (ORGO): Rasio rega marang prakiraan pendapatan

ORGO (Organogenesis) - tandha merek perusahaan

Organogenesis Holdings revenue dynamics are currently adapting to updated government reimbursements, as evidenced by the forward P/S ratio. The 0.30 level reflects the current value of this indicator. Growth is driven by leadership in tissue bioengineering for surgeons. Unique patents for treating complex wounds enable premium pricing, creating a local monopoly within the medical field.

ORGO organogenesis.com: Rasio kapitalisasi pasar marang pendapatan mangsa ngarep ing interval 04.07.2022 - 16.11.2026

ORGO (organogenesis.com): rincian analitis lan laporan miturut indikator

Pambiji fundamental perusahaan:organogenesis.com ORGO
Sampel barang Organogenesis Holdings

Organogenesis Holdings (ORGO) leverages unique patents and insurance codes to create a high barrier to entry for competitors within the regenerative medicine segment. The estimated forward P/S ratio quantifies this advantage by comparing the company's current market value with its projected annual revenue. This metric enables an assessment of the value of future earnings, neutralizing the time lags associated with standard reporting and accounting for cash flow gap risks. Analyzing the trend of the estimated forward P/S helps investors timely identify whether the asset is overbought or if there is a critical increase in the debt load.

Analisis pesaing

Multiplikator Forward P/S HCA (HCA Healthcare, Inc.)|Rasio rega marang pendapatan sing dikarepake THC (Tenet Healthcare)|FMS - Rasio rega marang prakiraan pendapatan|Rasio kapitalisasi pasar marang pendapatan mangsa ngarep solventum.com|EHC: Multiplikator Forward P/S|UHS - Rasio kapitalisasi marang dodolan sing dikarepake|DVA (DaVita Corp) - Multiplikator Forward P/S|RDNT: Rega forward marang dodolan|Multiplikator Forward P/S OPCH|SGRY (surgerypartners.com) - Rega forward marang dodolan|Multiplikator Forward P/S PINC (Premier Inc)|National Vision - Rasio rega marang prakiraan pendapatan|PGNY - Rasio rega marang prakiraan pendapatan|ARDT - Multiplikator Forward P/S|SEM: Multiplikator Forward P/S|astranahealth.com (ASTH) - Multiplikator Forward P/S|MD (mednax.com) - Multiplikator Forward P/S|Multiplikator Forward P/S usph.com|Multiplikator Forward P/S PNTG|NUTX (Nutex Health Corp) - Rega forward marang dodolan|Multiplikator Forward P/S AUNA (Auna S.A.)|SBC Medical Group Holdings Inc (SBC) - Rasio kapitalisasi pasar marang pendapatan mangsa ngarep|EOLS - Rasio rega marang prakiraan pendapatan|Rega forward marang dodolan CYH (Community Health Systems Inc)|SKIN (beautyhealth.com) - Multiplikator forward rega marang pendapatan|Kapitalisasi marang prakiraan pendapatan MDWD|Rasio rega marang prakiraan pendapatan biote Corp.|Rasio kapitalisasi pasar marang pendapatan mangsa ngarep thejoint.com JYNT|Multiplikator Forward P/S DCGO|Multiplikator forward rega marang pendapatan P3 Health PIII|Multiplikator Forward P/S GANX (Gain Therapeutics Inc.)|Multiplikator Forward P/S EUDA Health Holdings Limited EUDA|baselmedical.com - Multiplikator Forward P/S|CLGN: Rasio rega marang prakiraan pendapatan|Cuprina Holdings (Cayman) Ltd. (CUPR) - Rasio rega marang prakiraan pendapatan|Multiplikator forward rega marang pendapatan Concord Medical|AMS (American Shared Hospital Services Inc) - Multiplikator Forward P/S|MEDIROM Corp (MRM) - Rasio kapitalisasi marang dodolan sing dikarepake|Multiplikator Forward P/S ALBT|Rasio kapitalisasi marang dodolan sing dikarepake DIH Holding|Multiplikator Forward P/S XAGE (carmellcosmetics.com)|NIVF: Kapitalisasi marang prakiraan pendapatan|ATIP: Multiplikator forward rega marang pendapatan|CareMax Medical Group - Rasio rega marang pendapatan sing dikarepake|Kindly MD (KDLY) - Rasio rega marang prakiraan pendapatan|Kapitalisasi marang prakiraan pendapatan MODV|Rasio rega marang prakiraan pendapatan Novo Integrated Sciences Corp|Rasio kapitalisasi pasar marang pendapatan mangsa ngarep SunLink Health Systems SSY|Rasio rega marang prakiraan pendapatan IMAC Corp (BACK)